Publicacions en què col·labora amb Atanasio Pandiella Alonso (8)

2021

  1. JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

    Biomedicine and Pharmacotherapy, Vol. 144

2018

  1. A Small Molecule Tubulin Depolymerizing Agent Identified by a Phenotypic Drug Discovery Approach

    Journal of Molecular and Clinical Medicine, Vol. 1, Núm. 2, pp. 67-76

  2. Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia [Oncotarget, 8 (2017) (29679-29698)] Doi: 10.18632/oncotarget.11425

    Oncotarget

2017

  1. CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia

    Oncotarget, Vol. 8, Núm. 18, pp. 29679-29698

2012

  1. β-Lapachone analogs with enhanced antiproliferative activity

    European Journal of Medicinal Chemistry, Vol. 53, pp. 264-274

2011

  1. A modular approach to trim cellular targets in anticancer drug discovery

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 22, pp. 6641-6645

2010

  1. Enhancement of antiproliferative activity by molecular simplification of catalpol

    Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 7, pp. 2515-2523

  2. Mitotic arrest induced by a novel family of DNA topoisomerase II inhibitors

    Journal of Medicinal Chemistry, Vol. 53, Núm. 9, pp. 3835-3839